Member Directory

Company Profile:

Cerulea Clinical Trials delivers world class, high quality, and patient‑centred ophthalmic clinical research unit for Australian and international biopharmaceutical and medical technology (medtech) companies.
As a globally recognised and trusted partner, Cerulea conducts Phase I-IV clinical trials and, in partnership with the Centre for Eye Research Australia (CERA), plays a crucial role in investigator‑initiated studies, bridging the gap between laboratory discovery and real‑world patient care. We actively collaborate within Melbourne’s thriving biotech and medtech ecosystem, creating pathways for local innovators to bring new eye treatments and devices into the clinical trial setting.
With more than 20 years of clinical research experience, our dedicated team of investigators, nurses, study coordinators, and regulatory specialists provide exceptional expertise across the full research lifecycle. Our purpose‑built clinical trial facilities include a PC2 certified laboratory, a clinical trial pharmacy, administrative and procedural suites, and specialised capabilities for delivering cutting‑edge therapeutics, including gene and cell therapies.

We are committed to delivering an exceptional clinical trial experience for participants, clinicians, and sponsors alike, advancing discoveries that become tomorrow’s therapies and providing patients with early access to the medicines of the future.